Financial Performance - For the nine months ended September 30, 2025, the company reported total revenue of RMB 3,724.6 million, representing a year-on-year increase of 13.6% compared to RMB 3,278.9 million in 2024[4] - Net profit for the same period was RMB 183.8 million, a significant increase of 72.6% from RMB 106.5 million in 2024[4] - Adjusted net profit reached RMB 216.1 million, up 45.7% from RMB 148.3 million in the previous year[4] Business Growth - The company's F-end and B-end corporate health management business revenue grew by 21.5% year-on-year, with over 4,500 corporate clients served by the end of the reporting period[5] - The number of B-end paying users increased by 30.6% compared to the same period last year[5] - Home elderly care service users increased by 41% compared to the end of 2024, reflecting the company's focus on integrated health services[5] User Experience and Service Improvement - The company’s family doctor service covered over 40 million users by the end of the reporting period, enhancing user experience through AI and medical data capabilities[5] - The accuracy of complex disease MDT treatment plans improved to nearly 90%, while the average service cost per family doctor user decreased by approximately 52% year-on-year[5] Future Plans and Considerations - The company plans to continue strengthening collaboration with Ping An Group and enhance digital and AI capabilities to improve user satisfaction and service efficiency[6] - The financial data presented is unaudited and subject to change, as it is based on preliminary internal reviews by the board of directors[6]
平安好医生(01833) - 2025 Q3 - 季度业绩